Details for New Drug Application (NDA): 217685
✉ Email this page to a colleague
The generic ingredient in DOXYCYCLINE HYCLATE is doxycycline hyclate. There are twenty-eight drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.
Summary for 217685
Tradename: | DOXYCYCLINE HYCLATE |
Applicant: | Slate Run Pharma |
Ingredient: | doxycycline hyclate |
Patents: | 0 |
Suppliers and Packaging for NDA: 217685
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DOXYCYCLINE HYCLATE | doxycycline hyclate | INJECTABLE;INJECTION | 217685 | ANDA | Slate Run Pharmaceuticals, LLC | 70436-032 | 70436-032-82 | 10 VIAL, SINGLE-DOSE in 1 CARTON (70436-032-82) / 10 mL in 1 VIAL, SINGLE-DOSE (70436-032-35) |
DOXYCYCLINE HYCLATE | doxycycline hyclate | INJECTABLE;INJECTION | 217685 | ANDA | Slate Run Pharmaceuticals, LLC | 70436-201 | 70436-201-82 | 10 VIAL, SINGLE-DOSE in 1 CARTON (70436-201-82) / 20 mL in 1 VIAL, SINGLE-DOSE (70436-201-36) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 100MG BASE/VIAL | ||||
Approval Date: | Jun 21, 2024 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 200MG BASE/VIAL | ||||
Approval Date: | Jun 21, 2024 | TE: | AP | RLD: | No |
Complete Access Available with Subscription